| II-09 Jennifer Sheng Joint modeling of time-varying exposure data and progression-free survival in elotuzumab-treated patients with relapsed/refractory multiple myeloma Wednesday 15:10-16:30 |
| II-09 Jennifer Sheng Joint modeling of time-varying exposure data and progression-free survival in elotuzumab-treated patients with relapsed/refractory multiple myeloma Wednesday 15:10-16:30 |